go back

Tocilizumab Infusion for COVID-19, First Dose

South Dakota rates for HCPCS M0249

Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with COVID-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO) only, includes infusion and post administration monitoring, first dose

Rates data updated July 2026.

Facilitymedian $447 · 10th–90th $447$4470%50%$447Professionalmedian $447 · 10th–90th $447$5500%50%90th$447$500.0$1.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$446.68
Median
$446.68
Typical High
$446.68
Aetna
Setting
Professional
Modifier
Global
Typical Low
$446.68
Median
$446.68
Typical High
$446.68
Cigna
Setting
Facility
Modifier
Global
Typical Low
$446.68
Median
$446.68
Typical High
$446.68
Cigna
Setting
Professional
Modifier
Global
Typical Low
$446.68
Median
$446.68
Typical High
$549.54
Medica
Setting
Facility
Modifier
Global
Typical Low
$645.65
Median
$758.58
Typical High
$1,230.27
Medica
Setting
Professional
Modifier
Global
Typical Low
$398.11
Median
$588.84
Typical High
$954.99
Midlands
Setting
Professional
Modifier
Global
Typical Low
$707.95
Median
$707.95
Typical High
$707.95
United
Setting
Professional
Modifier
Global
Typical Low
$446.68
Median
$588.84
Typical High
$954.99
Wellmark
Setting
Professional
Modifier
Global
Typical Low
$446.68
Median
$446.68
Typical High
$446.68